Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Astrazeneca Plc | AZN | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 37.00 | 0.37% | 10,006.00 | 10:30:40 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 9,867.00 | 9,867.00 | 10,016.00 | 9,969.00 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| 21/02/2024 | Interim | GBP | 0.776 | 08/08/2024 | 09/08/2024 | 09/09/2024 |
| 08/02/2024 | Interim | GBP | 1.56 | 22/02/2024 | 23/02/2024 | 25/03/2024 |
| 09/02/2023 | Interim | GBP | 0.718 | 10/08/2023 | 11/08/2023 | 11/09/2023 |
| 09/02/2023 | Interim | GBP | 1.628 | 23/02/2023 | 24/02/2023 | 27/03/2023 |
| 10/02/2022 | Interim | GBP | 0.764 | 11/08/2022 | 12/08/2022 | 12/09/2022 |
| 10/02/2022 | Interim | GBP | 1.453 | 24/02/2022 | 25/02/2022 | 28/03/2022 |
| 11/02/2021 | Interim | GBP | 0.648 | 12/08/2021 | 13/08/2021 | 13/09/2021 |
| 05/11/2020 | Interim | GBP | 1.374 | 25/02/2021 | 26/02/2021 | 29/03/2021 |
| 24/10/2019 | Interim | GBP | 0.696 | 13/08/2020 | 14/08/2020 | 14/09/2020 |
| 24/10/2019 | Interim | GBP | 1.464 | 27/02/2020 | 28/02/2020 | 30/03/2020 |
| Top Posts |
|---|
Posted at 15/11/2024 17:18 by srichardson8 Pfizer peaked at $60 at the end of December 2021. It subsequently collapsed as the huge profits from its covid vaccines disappeared. Recent trading had been around $30 but it started to tumble again about a week ago, no doubt as rumours spread re Robert F Kennedy - the anti-vaxxer and conspiracy theorist - being appointed US Health Secretary.Last year Pfizer pre-tax profits fell from $35bn (Dec 22) to $1bn (Dec 23) though they are recovering this year - the last two quarters have shown a marked improvement, the forward p/e is a (fairly) modest x15.5. But the market obviously doesn't like the Kennedy news and the stock is down 4.5% as I write, pretty much the same price movement as GSK and AZN on the day. Moderna, really an RNA vaccine company, is down nearly 10%. |
Posted at 15/11/2024 14:38 by scepticalinvestor And that is why I am so bearishMajority of investment portfolio is in US mkt where I am up over 220% since 2021I have made the most from shorting UK blue chips though - mindblowing value destruction but unfortunately the UK Gov has for decades been more interested in other things.Seriously AZN shld be on abt 15000p but it is the UK so valued far less. And it is often unprofitable to go against the market. . . |
Posted at 15/11/2024 14:07 by scepticalinvestor Pfizer dropped abt 2% but the shares are not far off their 2 year high.Gsk / AZN on the other handIts UK plcAs i said, perfect mkt for shorters |
Posted at 15/11/2024 08:44 by wish i wasnt in rbs Maybe AZN will be reviewing their planned investment in the US following the nomination of a village idiot as the health secretary? |
Posted at 14/11/2024 09:30 by wskill Look at BRBY this morning in comparison to AZN no wonder the UK market is uninvestable AZM beat expectations and upgraded the share price fell on result day.Then we have BRBY a large loss today sales falling also huge lease obligations on shops in prime shopping areas and its romping ahead. |
Posted at 12/11/2024 10:37 by wskill Reading the results problems in China seems very low key as below from results looks unlikely that it will cause any lasting problems to AZN, and if it does its only 5% of company profits from which it may lose a few percent not all I would suggest.As previously disclosed, the Company is aware of a number of individual investigations by the Chinese authorities into current and former AstraZeneca employees. To the best of the Company's knowledge, the investigations include allegations of medical insurance fraud, illegal drug importation and personal information breaches. |
Posted at 12/11/2024 10:16 by fuji99 Agree Monty that China is the big hurdle for any positive share price movement regardless of the results and progress they make.The market hates uncertainty and these are questions that anyone can ask: What are the repercussions from China ? Is AZN going to be involved in Chinese courts ? Possible big fine if breaches are serious ? Any financial repercussion may hurt AZN numbers thus why the share price is "floating" at the moment. All these uncertainties will continue to weigh on the share price untill all is clarified once for all. |
Posted at 07/11/2024 17:48 by wskill Seems its in oncology results were massaged to qualify for state insurance but AZN is not being blamed ,sales of such drugs are less than 5% of chinese revenue and not greatly profitable.Looks like they have thrown out the baby with the bath water. |
Posted at 07/11/2024 12:49 by philanderer I'm holding what I've got but not adding until this mess is cleaned up.AZN now my smallest portfolio holding by value. |
Posted at 08/4/2024 13:47 by wad collector Really?Found 22 results: Blackhorse23 - 08 Apr 2024 - 11:28:43 - 6011 of 6012 AstraZeneca - AZN Money moved to APH Blackhorse23 - 05 Apr 2024 - 09:16:44 - 6009 of 6012 AstraZeneca - AZN Blackhorse23 - 21 Mar 2024 - 08:47:26 - 6002 of 6012 AstraZeneca - AZN Money moving to APH [LSE] , excellent profitable healthcare company Blackhorse23 - 21 Feb 2024 - 14:26:56 - 5995 of 6012 AstraZeneca - AZN Money moving to APH , excellent growth health care company Blackhorse23 - 12 Feb 2024 - 11:37:36 - 5981 of 6012 AstraZeneca - AZN Money moving to APH Blackhorse23 - 29 Jan 2024 - 15:32:08 - 5957 of 6012 AstraZeneca - AZN Blackhorse23 - 19 Jan 2024 - 11:52:35 - 5956 of 6012 AstraZeneca - AZN Ha ha hxxps://www.alliance Blackhorse23 - 18 Jan 2024 - 14:23:42 - 5954 of 6012 AstraZeneca - AZN Bought some APH today Blackhorse23 - 09 Jan 2024 - 11:01:43 - 5948 of 6012 AstraZeneca - AZN are they buying APH ?? |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
